UNASSIGNED:关于HBV相关性肝硬化患者腹水作为单一的首次失代偿事件的影响因素知之甚少,有必要为这些患者建立预测模型。
UNASSIGNED:纳入首次失代偿住院的乙型肝炎病毒相关肝硬化腹水患者,并将其分为训练队列(2010.03-2020.03)和验证队列(2020.04-2022.04)。所有患者均在入院前3个月内或入院后立即接受抗病毒治疗。再代偿被定义为患者的腹水消失,没有利尿剂,维持超过1年,没有其他失代偿并发症,肝细胞癌,或发生肝移植。列线图是从279名患者的训练队列中开发的,并在另72名患者的队列中进行了验证。
未经批准:完全,42.7%的失代偿患者实现了再补偿。根据Logistic回归和竞争风险分析的结果,发现了与再补偿相关的六个独立因素,这些因素包括列线图:年龄,丙氨酸氨基转移酶(ALT),白蛋白(ALB),血清钠(Na),甲胎蛋白(AFP),和维持病毒学应答(MVR)。通过外部验证,列线图的受试者工作特征曲线下面积(AUC)为0.848(95%CI:0.761,0.936),明显优于CTP,MELD,MELDNa,MELD3.0和ALBI等级。
未经批准:年龄,ALT,ALB,Na,法新社,和MVR与补偿密切相关。基于这些项目开发的列线图可以准确地预测乙肝肝硬化患者腹水作为单一的第一失代偿事件的再补偿的可能性。
Little is known about the influencing factors for
recompensation in HBV-related cirrhosis patients with ascites as the single first decompensating event and it\'s necessary to build a prediction model for these patients.
Hepatitis B virus-related cirrhosis patients with ascites hospitalized for the first decompensation were included and they were divided into the training cohort (2010.03-2020.03) and the validation cohort (2020.04-2022.04). All patients received antiviral therapy within 3 months before admission or immediately after admission.
Recompensation is defined as the patient\'s ascites disappeared without diuretics, which were maintained for more than 1 year and no other decompensated complications, hepatocellular carcinoma, or liver transplantation occurred. The nomogram was developed from a training cohort of 279 patients and validated in another cohort of 72 patients.
Totally, 42.7% of the decompensated patients achieved
recompensation. According to the results of logistic regression and competing risk analysis, six independent factors associated with recompensation were found and these factors comprised the nomogram: age, alanine aminotransferase (ALT), albumin (ALB), serum sodium (Na), alpha-fetoprotein (AFP), and maintained virological response (MVR). Through external validation, the area under the receiver operating characteristic curve (AUC) of the nomogram was 0.848 (95% CI: 0.761, 0.936), which was significantly better than CTP, MELD, MELDNa, MELD 3.0, and ALBI grade.
Age, ALT, ALB, Na, AFP, and MVR are closely related to the
recompensation. The nomogram developed based on these items can accurately predict the possibility of
recompensation in hepatitis B cirrhosis patients with ascites as the single first decompensating event.